GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 12 analysts with an average price target of $32.75. This is a potential upside of $-10.75 (-24.71%) from yesterday's end of day stock price of $43.5.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 109 price targets and 86 ratings on display. The stock rating distribution of GSK is 23.81% BUY, 66.67% HOLD and 9.52% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.73% with an average time for these price targets to be met of 79.88 days.

Highest price target for GSK is $48, Lowest price target is $19.52, average price target is $32.75.

Most recent stock forecast was given by MARK PURCELL from MORGAN STANLEY on 23-Jan-2024. First documented stock forecast 28-Jul-2014.

Currently out of the existing stock ratings of GSK, 5 are a BUY (23.81%), 14 are a HOLD (66.67%), 2 are a SELL (9.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

44

$0.5 (1.15%)

18.72

3 months 12 days ago

0/14 (0%)

$5.1 (13.11%)

Buy

48

$4.5 (10.34%)

39

4 months 2 days ago

1/3 (33.33%)

$9.46 (24.55%)

265

Hold

19.52

$-23.98 (-55.13%)

18.9

8 months 21 days ago

0/3 (0%)

$-14.87 (-43.24%)

Hold

19.58

$-22.45 (-53.41%)

19.96

1 years 14 days ago

0/2 (0%)

$-16.05 (-45.05%)

Buy

21.66

1 years 1 months 18 days ago

0/13 (0%)

$-19.7 (-47.63%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 79.88 days on average for the stock forecasts to be realized with a an average price target met ratio 13.73

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

JUSTIN SMITH

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Justin Smith works at SOCGEN and has 5 price targets and 3 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

Peter Welford with highest potential upside - $4.5

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Emily Field with lowest potential downside - -$27.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?